S2095Temporary National Codes (Non-Medicare)
Transcatheter occlusion or embolization for tumor destruction, percutaneous,
Short description: Transcath emboliz microspher
- Effective date
- January 1, 2004
- Termination date
- —
Related codes (S-series)
S0012Butorphanol tartrate, nasalS0013Esketamine, nasal sprayS0014Tacrine hydrochloride, 10 mgS0017Injection, aminocaproic acidS0020Injection, bupivicaine hydroS0021Injection, cefoperazone sodS0023Injection, cimetidine hydrocS0028Injection, famotidine, 20 mgS0030Injection, metronidazoleS0032Injection, nafcillin sodiumS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole
Frequently asked questions
What is HCPCS code S2095?
S2095 is a HCPCS Level II code for Transcatheter occlusion or embolization for tumor destruction, percutaneous,.
What category is HCPCS code S2095 in?
S2095 falls under the Temporary National Codes (Non-Medicare) category of HCPCS Level II.
When did HCPCS code S2095 become effective?
S2095 has been effective since January 1, 2004, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.